Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.47 USD | 0.00% | -1.98% | -21.14% |
Business Summary
Number of employees: 17
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Brady
CEO | Chief Executive Officer | 54 | 19-08-31 |
Nicholas Maestas
DFI | Director of Finance/CFO | 44 | 21-07-11 |
Darrin Bomba
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Sam Whiting
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-10-31 |
Comptroller/Controller/Auditor | 36 | 22-05-31 | |
Sharon Sakai
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 21-06-30 | |
Geoffrey Nichol
BRD | Director/Board Member | 69 | 19-11-30 |
Mike Raab Raab
CHM | Chairman | 59 | 20-12-31 |
Ronit Simantov
BRD | Director/Board Member | 59 | 21-08-05 |
Stephen Brady
CEO | Chief Executive Officer | 54 | 19-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,217,265 | 22,203,364 ( 99.94 %) | 0 | 99.94 % |
Company contact information
Tempest Therapeutics, Inc.
2000 Sierra Point Parkway Suite 400
94005, Brisbane
+
http://www.tempesttx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.14% | 77.09M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- TPST Stock
- Company Tempest Therapeutics, Inc.